David K. Cheng

In the News

• China Business Law Journal

  Five compliance advisers assist China’s third largest e-commerce listing

  NP is mentioned for serving as US compliance counsel for client Zibuyu International Ltd. in the clothing and footwear company’s recent listing with Hong Kong Exchanges and Clearing Limited (HKEX). Zibuyu is represented by China and Asia-Pacific practice managing partner David Cheng, of the Corporate group.

  Nov 15, 2022
• San Francisco Business Times

  The quest for mutual benefit: The complicated China-U.S. business relationship gets more complicated

  This article covers a recent “Bridge from China” event, sponsored by NP, that included discussion of how the pandemic has affected cross-border business, and how to potentially tackle complex nuances of U.S.-China political and business relationships. David Cheng, chair and managing partner of NP’s China & Asia Pacific practice, served as a panelist, and David Kaufman, director of Global Strategies, co-moderated the panel discussion.
  April 28, 2022
• The American Lawyer

  Deal Watch: Private equity hits new heights

  This article on the surge in private equity deals includes NP for advising the owners of skin care brand Obagi in its $1.2 billion business combination agreement with Waldencast Acquisition Corp. and the spinoff of Obagi’s operations in China.

  The NP team was led by David Cheng, chair and managing partner of the firm's China and Asia-Pacific practice, and New York City Corporate partners Michael Smith and Richard Langan. The team that advised Obagi also included Chicago Corporate partner David Brown, Rochester Corporate partner Jeremy Wolk, Washington, DC Complex Commercial Disputes partner and Antitrust team leader Gordon Lang, and Washington, DC Corporate senior counsel Kenneth Silverberg. Other members of the team included Boston Corporate associate Anthony Bova and Chinese legal consultant Kelly Xiang.

  Nov 22, 2021
• Bloomberg Law

  Four firms lead three-way SPAC to create new beauty platform

  This article covering a roughly $1.2 billion merger of skin care and beauty brands with a special purpose acquisition company mentions NP for advising the owners of skin care brand Obagi in its business combination agreement with Waldencast Acquisition Corp. and the spinoff of Obagi's operations in China.

  The NP team was led by David Cheng, chair and managing partner of the firm's China and Asia-Pacific practice, and New York City Corporate partners Michael Smith and Richard Langan. The team that advised Obagi also included Chicago Corporate partner David Brown, Rochester Corporate partner Jeremy Wolk, Washington, DC Complex Commercial Disputes partner and Antitrust team leader Gordon Lang, and Washington, DC Corporate senior counsel Kenneth Silverberg. Other members of the team included Boston Corporate associate Anthony Bova and Chinese legal consultant Kelly Xiang.

  Nov 18, 2021
• San Francisco Business Times

  After the turbulent Trump years ,what will it take for the U.S. and China to reset their relationship?

  This article covers a recent “Bridge from China“ event, sponsored by NP, that included discussion of how the pandemic has affected cross-border business, geopolitical tensions of recent years, and what the administration change could mean for U.S. businesses wanting to do business in China. David Cheng, chair and managing partner of NP’s China & Asia Pacific practice, served as a panelist and David Kaufman, director of Global Strategies, co-moderated the panel discussion.
  Feb 26, 2021
• Rochester Business Journal

  Coronavirus putting crimp on firms doing business in China

  Rochester Corporate partner Jeremy Wolk authored this column about how employers with business operations in China are responding to the coronavirus outbreak and related travel restrictions. The article is based on an alert by Hong Kong Corporate partner David Cheng, Los Angeles Labor and Employment partner Benjamin Kim, San Francisco Labor and Employment senior counsel Jeffrey Tanenbaum and associate Rachel Conn, and Director of Global Strategies David Kaufman
  Feb 21, 2020
• Forbes

  What trade trouble? China loosens foreign ownership of financial sector one year early

  This Forbes article describing China’s efforts to open its market to foreign investors.
  July 20, 2019
• Asian Legal Business

  A Slow and Steady Approach for Nixon Peabody

  China & Asia-Pacific chair David Cheng and Global Strategies Committee chair and IP Counseling & Transactions practice group leader Jeff Costellia are quoted in this article focused on Nixon Peabody’s strategic expansion in Asia.
  Oct 4, 2016
• Law360

  Over A Dozen Firms Guided Largest Q1 Real Estate Deals

  The $390M purchase of a premier site within New York’s South Street Seaport Subdistrict by Oceanwide Center NY LLC, a subsidiary of Oceanwide Holdings Co., is among the 10 largest Q1 real estate deals. Nixon Peabody advised Oceanwide on the transaction. The coverage notes the deal team was led by partners Denise Pursley, Colette Dafoe and David Cheng.
  May 4, 2016
• Apple Daily (a Hong Kong newspaper)

  HK intends to create an online platform for house co-purchases

  Chair and managing partner of the firm’s China and Asia-Pacific practice David Cheng provides commentary on the legal issues with online money raising platforms in Hong Kong.
  Oct 19, 2015
• Apple Daily (a Hong Kong newspaper)

  HKMA said whether to give license would depend on situation

  Chair and managing partner of the firm’s China and Asia-Pacific practice David Cheng provides commentary on the legal issues surrounding P2P lending.
  Oct 19, 2015
• Law360

  Nixon Peabody, CWL Partners Join Forces in Hong Kong

  This feature story features the Nixon Peabody CWL combination. Quotes are included from managing partner and CEO Andrew Glincher, partner and chair of the firm’s China and Asia Pacific practice David Cheng, and Nixon Peabody CWL managing partner Kenneth Wong.
  Oct 8, 2015